Largest Vaccines companies in Canada by Market Capitalization
Canada
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 1.15 B |
Jan. 31, 2025 | USD 7.95 | -0.62% |
|
Canada |
|
| 2 |
USD 936.31 M |
Jan. 31, 2025 | USD 3.17 | -1.86% |
|
Canada |
|
| 3 |
USD 118.04 M |
Feb. 5, 2025 | USD 1.45 | 3.65% |
|
Canada |
|
| 4 |
USD 70.05 M |
Feb. 5, 2025 | USD 1.52 | 2.02% |
|
Canada |
|
| 5 |
USD 67.72 M |
Feb. 5, 2025 | USD 0.15 | -5.56% |
|
Canada |
|
| 6 |
USD 66.63 M |
Feb. 5, 2025 | USD 0.85 | -3.04% |
|
Canada |
|
| 7 |
USD 56.55 M |
Feb. 5, 2025 | USD 0.73 | 3.09% |
|
Canada |
|
| 8 |
USD 32.65 M |
Feb. 5, 2025 | USD 1.86 | 5.08% |
|
Canada |
|
| 9 |
USD 13.34 M |
Feb. 5, 2025 | USD 4.53 | 8.70% |
|
Canada |
|
| 10 |
USD 6.61 M |
Jan. 31, 2025 | USD 1.91 | 1.06% |
|
Canada |
|
| 11 |
USD 2.95 M |
Feb. 5, 2025 | USD 0.89 | -2.92% |
|
Canada |
Frequently Asked Questions
-
Which Vaccines company in Canada has the highest Market Capitalization ?
The Vaccines company in Canada with the highest Market Capitalization is Aurinia Pharmaceuticals Inc. (NasdaqGM: AUPH) at USD 1.15 B.
-
Which Vaccines company in Canada has the lowest Market Capitalization ?
The Vaccines company in Canada with the lowest Market Capitalization is XORTX Therapeutics Inc. (TSXV: XRTX.V) at USD 2.95 M.
-
What are the top 10 Vaccines companies in Canada by Market Capitalization ?
The top 10 Vaccines companies in Canada by Market Capitalization are Aurinia Pharmaceuticals Inc., AbCellera Biologics Inc., Cardiol Therapeutics Inc., Theratechnologies Inc., Ondine Biomedical Inc., Medicenna Therapeutics Corp., Oncolytics Biotech Inc., Lexaria Bioscience Corp., BriaCell Therapeutics Corp. and Edesa Biotech, Inc..
-
What are the bottom 10 Vaccines companies in Canada by Market Capitalization ?
The bottom 10 Vaccines companies in Canada by Market Capitalization are XORTX Therapeutics Inc., Edesa Biotech, Inc., BriaCell Therapeutics Corp., Lexaria Bioscience Corp., Oncolytics Biotech Inc., Medicenna Therapeutics Corp., Ondine Biomedical Inc., Theratechnologies Inc., Cardiol Therapeutics Inc. and AbCellera Biologics Inc..
